St Louis Trust’s AbbVie ABBV Stock Holding History

St Louis Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.8M	Hold	8,278	–	–	0.21%	58
2025 Q4	$1.89M	Hold	8,278	–	–	0.22%	56
2025 Q3	$1.92M	Hold	8,278	–	–	0.24%	47
2025 Q2	$1.54M	Hold	8,278	–	–	0.2%	49
2025 Q1	$1.73M	Buy	8,278 +1,189	+17%	+$231K	0.25%	50
2024 Q4	$1.26M	Hold	7,089	–	–	0.18%	58
2024 Q3	$1.4M	Sell	7,089 -1,189	-14%	-$222K	0.2%	56
2024 Q2	$1.42M	Hold	8,278	–	–	0.22%	54
2024 Q1	$1.51M	Buy	8,278 +1,189	+17%	+$205K	0.24%	54
2023 Q4	$1.1M	Hold	7,089	–	–	0.19%	56
2023 Q3	$1.06M	Hold	7,089	–	–	0.2%	56
2023 Q2	$955K	Hold	7,089	–	–	0.18%	60
2023 Q1	$1.13M	Hold	7,089	–	–	0.23%	51
2022 Q4	$1.15M	Sell	7,089 -64	-0.9%	-$9.81K	0.24%	52
2022 Q3	$766K	Buy	7,153 +91	+1%	+$13.1K	0.22%	57
2022 Q2	$1.08M	Buy	7,062 +23	+0.3%	+$3.52K	0.23%	50
2022 Q1	$1.14M	Sell	7,039 -237	-3%	-$34.4K	0.24%	49
2021 Q4	$985K	Buy	7,276 +31	+0.4%	+$3.66K	0.21%	62
2021 Q3	$782K	Buy	7,245 +30	+0.4%	+$3.43K	0.21%	61
2021 Q2	$813K	Buy	7,215 +29	+0.4%	+$3.27K	0.2%	56
2021 Q1	$777K	Buy	+7,186	New	+$769K	0.19%	58
2020 Q4	–	Sell	-7,122	Closed	-$624K	–	73
2020 Q3	$624K	Buy	7,122 +32	+0.5%	+$3.01K	0.2%	60
2020 Q2	$696K	Sell	7,090 -124	-2%	-$10.9K	0.21%	54
2020 Q1	$549K	Buy	7,214 +34	+0.5%	+$2.9K	0.21%	57
2019 Q4	$636K	Buy	7,180 +32	+0.4%	+$2.66K	0.18%	55
2019 Q3	$542K	Buy	7,148 +43	+0.6%	+$2.95K	0.17%	56
2019 Q2	$517K	Buy	7,105 +34	+0.5%	+$2.67K	0.16%	57
2019 Q1	$570K	Buy	7,071 +34	+0.5%	+$2.78K	0.18%	57
2018 Q4	$649K	Buy	7,037 +26	+0.4%	+$2.29K	0.24%	49
2018 Q3	$663K	Buy	7,011 +25	+0.4%	+$2.37K	0.23%	54
2018 Q2	$648K	Sell	6,986 -5,978	-46%	-$584K	0.22%	61
2018 Q1	$1.23M	Buy	12,964 +7,515	+138%	+$826K	0.42%	44
2017 Q4	$527K	Buy	5,449 +2,016	+59%	+$190K	0.21%	50
2017 Q3	$305K	Buy	3,433 +22	+0.6%	+$1.68K	0.14%	46
2017 Q2	$248K	Buy	3,411 +23	+0.7%	+$1.55K	0.11%	48
2017 Q1	$221K	Buy	3,388 +25	+0.7%	+$1.57K	0.09%	53
2016 Q4	$211K	Sell	3,363 -9	-0.3%	-$549	0.1%	51
2016 Q3	$213K	Buy	3,372 +20	+0.6%	+$1.29K	0.1%	50
2016 Q2	$208K	Sell	3,352 -1,248	-27%	-$76K	0.11%	49
2016 Q1	$263K	Buy	+4,600	New	+$256K	0.14%	53

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

St Louis Trust's ABBV Position: Q1 2026 in Review

St Louis Trust held its AbbVie (ABBV) position steady in Q1 2026 at 8,278 shares worth $1.8M. The position accounts for 0.21% of the portfolio, ranked #58.

St Louis Trust first reported a position in ABBV in Q1 2016 and has held it in 40 quarters since. The position peaked at $1.92M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

St Louis Trust held 8,278 shares of AbbVie worth $1.8M as of Q1 2026.
St Louis Trust left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.21% of St Louis Trust's portfolio in Q1 2026, its #58 holding.
St Louis Trust first reported a position in AbbVie in Q1 2016 and has held it in 40 quarters since.
St Louis Trust's AbbVie position peaked at $1.92M in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on St Louis Trust's 13F filing for Q1 2026, filed 14 May 2026.